19 June 2013
Keywords: positive, results, reopro, capture, trial, centocor, halted
Article | 08 January 1996
Centocor has halted the 1,400-patient CAPTURE trial of its glycoprotein
IIb/IIIa antibody, ReoPro (abciximab; 7E3), in refractory unstable
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 January 1996
8 January 1996
22 January 1996
© 2013 thepharmaletter.com